Back to search

Article

How Structural Modifications of Insulin Icodec Contributes to Its Prolonged Duration of Action: A Structural and Biophysical Perspective

2023-11-16

Abstract excerpt

Insulin icodec of Novo Nordisk is a novel long-acting insulin analogue that exhibits an extended duration of action, providing a promising treatment option for individuals with diabetes. It has been reported that the incorporation of fatty acid moieties into insulin icodec plays a crucial role in its prolonged action, as these fatty acid chains facilitate the formation of stable hexameric structures, thereby delay...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
623cfd16-cf3a-5e4a-8f8a-e52179c58cae
DOI
10.20944/preprints202311.1048.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
How Structural Modifications of Insulin Icodec Contributes to Its Prolonged Duration of Action: A Structural and Biophysical PerspectiveDOI 10.20944/preprints202311.1048.v1
Select a neighboring publication to make it the new centre.